{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:53:40Z","timestamp":1790146420810,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ygyno.2018.01.030","type":"journal-article","created":{"date-parts":[[2018,3,4]],"date-time":"2018-03-04T07:12:44Z","timestamp":1520147564000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US"],"prefix":"10.1016","volume":"149","author":[{"given":"Cheng-I","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-may","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9470-4839","authenticated-orcid":false,"given":"Amandeep","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.01.030_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0010","first-page":"107","article-title":"Carcinoma of the ovary","volume":"6","author":"Heintz","year":"2001","journal-title":"J. Epidemiol. Biostat."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0015","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/IGC.0000000000000477","article-title":"Should all cases of high-grade serous ovarian, tubal, and primary peritoneal carcinomas be reclassified as tubo-ovarian serous carcinoma?","volume":"25","author":"Moss","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/his.13248","article-title":"High-grade serous carcinoma of tubo-ovarian origin: recent developments","volume":"71","author":"Singh","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0045","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/aogs.12948","article-title":"Ovarian and tubal cancer in Denmark: an update on incidence and survival","volume":"95","author":"Gottschau","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"9","key":"10.1016\/j.ygyno.2018.01.030_bb0050","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00432-017-2422-6","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes","volume":"143","author":"Rottmann","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"188","key":"10.1016\/j.ygyno.2018.01.030_bb0055","first-page":"e1","article-title":"Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas","volume":"212","author":"Usach","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0065","author":"2001\u20132014 Database"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0070","author":"United States Census Bureau"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0075","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat. Med."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0080","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov\/seerstat) version 8.3.4. SEER*Stat Database: NPCR and SEER Incidence - Public Use Data - 2001\u20132014 - jbk 062817."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat. Med."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0090","series-title":"Version 4.5.0.1","author":"Joinpoint Regression Program","year":"2016"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0095","series-title":"Epidemiology of Cancer in Texas. Incidence Analyzed by Type, Ethnic Group, and Geographic Location","author":"McDonald","year":"1978"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/02841868909111173","article-title":"Primary carcinoma of the fallopian tube. A retrospective study of patients reported to the Danish Cancer Registry in a five-year period","volume":"28","author":"Pfeiffer","year":"1989","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0090-8258(89)90051-6","article-title":"Incidence of malignant fallopian tube tumors","volume":"35","author":"Rosenblatt","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.10970","article-title":"Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953\u201397","volume":"104","author":"Riska","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0115","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/01443610500292395","article-title":"Primary fallopian tube carcinoma \u2014 the experience of a UK cancer centre and a review of the literature","volume":"25","author":"Clayton","year":"2005","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/S1807-59322011000100013","article-title":"Fallopian tube origin of supposed ovarian high-grade serous carcinomas","volume":"66","author":"Diniz","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0135","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0140","author":"College of American Pathologists"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0145","author":"College of American Pathologists"},{"key":"10.1016\/j.ygyno.2018.01.030_bb0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PGP.0000000000000336","article-title":"The fallopian tube origin and primary site assignment in extrauterine high-grade serous carcinoma: findings of a survey of pathologists and clinicians","volume":"36","author":"McCluggage","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/AOG.0000000000002243","article-title":"The evolution of and evidence for opportunistic salpingectomy","volume":"130","author":"Dilley","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"471","key":"10.1016\/j.ygyno.2018.01.030_bb0160","first-page":"e1","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0165","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ygyno.2007.09.018","article-title":"The incidence of primary fallopian tube cancer in the United States","volume":"107","author":"Stewart","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0170","first-page":"599","article-title":"Linkseitiges tubenkarzinom rechtseitige karzinomatose tuboovarial cyste","volume":"40","author":"Latzko","year":"1916","journal-title":"Zentralbl. Gynakol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00006254-199405000-00026","article-title":"Primary carcinoma of the fallopian tube: a 20-year literature review","volume":"49","author":"Nordin","year":"1994","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tjog.2011.01.031","article-title":"Primary fallopian tube carcinoma: clinicopathological analysis of 12 cases","volume":"50","author":"Ou","year":"2011","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0185","first-page":"138","article-title":"Primary tubal carcinoma: a retrospective analysis of four cases with a literature review","volume":"19","author":"Friedrich","year":"1998","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0190","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ygyno.2007.09.027","article-title":"Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary","volume":"107","author":"Moore","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0195","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/gyno.2000.5840","article-title":"Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry","volume":"78","author":"Piver","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.030_bb0200","author":"Centers for Disease Control and Prevention"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818300696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818300696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T13:21:11Z","timestamp":1535030471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818300696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0090825818300696"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.030","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}